Literature DB >> 29395118

New Insights into Modes of GPCR Activation.

Wenjing Wang1, Yuhui Qiao1, Zijian Li2.   

Abstract

In classical G-protein-coupled receptor (GPCR) activation, GPCRs couple to a variety of heterotrimeric G proteins on the membrane and then activate downstream signaling pathways. More recently, GPCRs have been found to couple to different effector proteins, including different G protein subtypes and regulatory proteins, such as arrestins. Some novel modes of GPCR activation have been proposed to explain their complex behaviors. In this review, we summarize the main novel modes of GPCR activation, including biased activation, intracellular activation, dimerization activation, transactivation, and biphasic activation. In addition, we also discuss the relationship among the five modes to show the complex picture of GPCR activation. The complex activation modes regulate precisely GPCR downstream signaling, including physiological and pathological signaling. Thus, there is the potential to develop GPCR precision drugs that target precise GPCR activation modes to accurately strengthen their beneficial functions and block specific pathological processes.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  G-protein-coupled receptor (GPCR); biased activation; biphasic activation; dimerization activation; internalized activation; transactivation

Mesh:

Substances:

Year:  2018        PMID: 29395118     DOI: 10.1016/j.tips.2018.01.001

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  46 in total

Review 1.  Function and therapeutic potential of G protein-coupled receptors in epididymis.

Authors:  Daolai Zhang; Yanfei Wang; Hui Lin; Yujing Sun; Mingwei Wang; Yingli Jia; Xiao Yu; Hui Jiang; Wenming Xu; Jin-Peng Sun; Zhigang Xu
Journal:  Br J Pharmacol       Date:  2020-10-29       Impact factor: 8.739

Review 2.  Neutrophil Signaling That Challenges Dogmata of G Protein-Coupled Receptor Regulated Functions.

Authors:  Claes Dahlgren; André Holdfeldt; Simon Lind; Jonas Mårtensson; Michael Gabl; Lena Björkman; Martina Sundqvist; Huamei Forsman
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-11

Review 3.  New Advances in Targeting the Resolution of Inflammation: Implications for Specialized Pro-Resolving Mediator GPCR Drug Discovery.

Authors:  Julia Park; Christopher J Langmead; Darren M Riddy
Journal:  ACS Pharmacol Transl Sci       Date:  2020-01-20

Review 4.  Formyl peptide receptor 2 as a potential therapeutic target for inflammatory bowel disease.

Authors:  Wen-Sheng Yang; Jing-Lin Wang; Wei Wu; Guang-Fei Wang; Jun Yan; Qing Liu; Xiao-Yan Wu; Qing-Tong Zhou; De-Hua Yang; Ming-Wei Wang; Zhi-Ping Li
Journal:  Acta Pharmacol Sin       Date:  2022-07-15       Impact factor: 7.169

5.  Mechanism of Hormone Peptide Activation of a GPCR: Angiotensin II Activated State of AT1R Initiated by van der Waals Attraction.

Authors:  Khuraijam Dhanachandra Singh; Hamiyet Unal; Russell Desnoyer; Sadashiva S Karnik
Journal:  J Chem Inf Model       Date:  2019-01-16       Impact factor: 4.956

Review 6.  Oxytocin in the Male Reproductive Tract; The Therapeutic Potential of Oxytocin-Agonists and-Antagonists.

Authors:  Beatrix Stadler; Michael R Whittaker; Betty Exintaris; Ralf Middendorff
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-22       Impact factor: 5.555

7.  RTK signaling requires C3ar1/C5ar1 and IL-6R joint signaling to repress dominant PTEN, SOCS1/3 and PHLPP restraint.

Authors:  Michael G Strainic; Elliot Pohlmann; Christopher C Valley; Ajay Sammeta; Wasim Hussain; Diane S Lidke; M Edward Medof
Journal:  FASEB J       Date:  2019-12-13       Impact factor: 5.191

8.  β-arrestin 2 is essential for fluoxetine-mediated promotion of hippocampal neurogenesis in a mouse model of depression.

Authors:  Chen-Xin Li; Ying Zheng; Hong Zhu; Cheng-Wu Li; Zhang He; Cong Wang; Jian-Hua Ding; Gang Hu; Ming Lu
Journal:  Acta Pharmacol Sin       Date:  2021-02-01       Impact factor: 6.150

Review 9.  Insights into Nuclear G-Protein-Coupled Receptors as Therapeutic Targets in Non-Communicable Diseases.

Authors:  Salomé Gonçalves-Monteiro; Rita Ribeiro-Oliveira; Maria Sofia Vieira-Rocha; Martin Vojtek; Joana B Sousa; Carmen Diniz
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-07

Review 10.  Activated protein C, protease activated receptor 1, and neuroprotection.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Blood       Date:  2018-06-04       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.